Unión Europea - español - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacunas - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. el uso de esta vacuna debe estar en conformidad con las recomendaciones oficiales.

Chile - español - ISPC (Instituto de Salud Pública de Chile)

tecnofarma s.a. - davesomeran; elasomeran - davesomerÁn (1) 25 mcg; elasomerÁn (2) 25 mcg - indicada para la inmunización activa para prevenir el covid-19, causada por el virus sars-cov-2, en personas de 6 años y mayores que han recibido previamente al menos la primovacunación contra covid-19.

Chile - español - ISPC (Instituto de Salud Pública de Chile)

tecnofarma s.a. - davesomeran; elasomeran - davesomerÁn (1) 25 mcg; elasomerÁn (2) 25 mcg - indicada para la inmunización activa para prevenir el covid-19, causada por el virus sars-cov-2, en personas de 6 años y mayores que han recibido previamente al menos la primovacunación contra covid-19.

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

farmaceutica biotech sociedad anonima cerrada - biotech s.a.c. - droguerÍa - tableta - por tableta - - glimepirida

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

farmaceutica biotech sociedad anonima cerrada - biotech s.a.c. - droguerÍa - tableta - por capsula - - glibenclamida

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

farmaceutica biotech sociedad anonima cerrada - biotech s.a.c. - droguerÍa - clorhidrato de metformina; - tableta recubierta - por tableta - - metformina

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

farmaceutica biotech sociedad anonima cerrada - biotech s.a.c. - droguerÍa - tableta - por tableta - - glimepirida

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

farmaceutica biotech sociedad anonima cerrada - biotech s.a.c. - clorhidrato de metformina; - tableta - por mililitro mg - metformina

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

farmaceutica biotech sociedad anonima cerrada - biotech s.a.c. - clorhidrato de metformina; - tableta - por vial mg - metformina

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

farmaceutica biotech sociedad anonima cerrada - biotech s.a.c. - clorhidrato de metformina; - tableta recubierta - por tableta; clorhidrato de metformina 1000.000000 mg; - metformina